Trial Details

Recruiting
Basic Information
Clinical ID c2064
Identifier NCT06483373
Trial Title A Single and Multiple Dose-escalation, and Food Effects of Phase I Clinical Study to Evaluate the Tolerability/Safety/Pharmacokinetics of SPH7854 Granules in Healthy Subjects.
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Inflammatory Bowel Disease
Interventions Drug: SPH7854;Drug: Placebo
Participant Information
Sponsor Shanghai Pharmaceuticals Holding Co., Ltd
City -
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type Interventional
Phase EARLY_PHASE1
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -